Production of 177Lu at the new research reactor FRM-II: Irradiation yield of 176Lu177Lu

This publication has 23 references indexed in Scilit:

• On the preparation of a therapeutic dose of 177Lu-labeled DOTA–TATE using indigenously produced 177Lu in medium flux reactor
  Applied Radiation and Isotopes, 2007
• Phase I Trial of ¹⁷⁷Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer
  Journal of Clinical Oncology, 2005
• A process for the separation of 177Lu from neutron irradiated 176Yb targets
  Applied Radiation and Isotopes, 2005
• Nuklearmedizin: 177Lu-DOTA-Rituximab
  Swiss Medical Forum ‒ Schweizerisches Medizin-Forum, 2003
• Recommended nuclear data for use in the k0 standardization of neutron activation analysis
  Atomic Data and Nuclear Data Tables, 2003
• Production of no-carrier-added 177Lu via the 176Yb(n, &;#947;)177Yb &;#8594; 177Lu process
  Journal of Radioanalytical and Nuclear Chemistry, 2003
• 177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliation
  Applied Radiation and Isotopes, 2002
• Temperature Dependence of the Westcott g-factor for Neutron Reactions in Activation Analysis
  Published by Walter de Gruyter GmbH ,1999
• Nuclear medicine program progress report for quarter ending September 30, 1995
  Published by Office of Scientific and Technical Information (OSTI) ,1995
• Separation of carrier-free lutetium-177 from neutron irradiated natural ytterbium target
  Journal of Radioanalytical and Nuclear Chemistry, 1994